ClinicalTrials.gov record
Fesoterodine Flexible Dose Study
ClinicalTrials.gov ID: NCT00536484
Public ClinicalTrials.gov record NCT00536484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Overactive Bladder.
Study identification
- NCT ID
- NCT00536484
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 896 participants
Conditions and interventions
Conditions
Interventions
- Fesoterodine Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Feb 29, 2008
- Completion
- Feb 29, 2008
- Last update posted
- Sep 14, 2009
2007 – 2008
United States locations
- U.S. sites
- 95
- U.S. states
- 31
- U.S. cities
- 84
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Mobile | Alabama | 36608 | — |
| Pfizer Investigational Site | Chandler | Arizona | 85225 | — |
| Pfizer Investigational Site | Peoria | Arizona | 85381 | — |
| Pfizer Investigational Site | Tucson | Arizona | 85741 | — |
| Pfizer Investigational Site | Rancho Cordova | California | 95670 | — |
| Pfizer Investigational Site | Sacramento | California | 95825 | — |
| Pfizer Investigational Site | San Diego | California | 92103 | — |
| Pfizer Investigational Site | Denver | Colorado | 80210 | — |
| Pfizer Investigational Site | Denver | Colorado | 80211 | — |
| Pfizer Investigational Site | Denver | Colorado | 80218 | — |
| Pfizer Investigational Site | Englewood | Colorado | 80112 | — |
| Pfizer Investigational Site | New Britain | Connecticut | 06052 | — |
| Pfizer Investigational Site | Aventura | Florida | 33180 | — |
| Pfizer Investigational Site | Bonita Springs | Florida | 34134 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Lake Worth | Florida | 33461 | — |
| Pfizer Investigational Site | Miami | Florida | 33143 | — |
| Pfizer Investigational Site | Miami | Florida | 33176 | — |
| Pfizer Investigational Site | Naples | Florida | 34102 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33024 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33709 | — |
| Pfizer Investigational Site | Stuart | Florida | 34996 | — |
| Pfizer Investigational Site | Tallahassee | Florida | 32308 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60610 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47713 | — |
| Pfizer Investigational Site | Jeffersonville | Indiana | 47130 | — |
| Pfizer Investigational Site | Newburgh | Indiana | 47630 | — |
| Pfizer Investigational Site | Iowa City | Iowa | 52242 | — |
| Pfizer Investigational Site | Overland Park | Kansas | 66210 | — |
| Pfizer Investigational Site | Overland Park | Kansas | 66215 | — |
| Pfizer Investigational Site | Pratt | Kansas | 67124 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40509 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40207 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40291 | — |
| Pfizer Investigational Site | Madisonville | Kentucky | 42431 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21204 | — |
| Pfizer Investigational Site | Bel Air | Maryland | 21014 | — |
| Pfizer Investigational Site | Milford | Massachusetts | 01757 | — |
| Pfizer Investigational Site | Springfield | Massachusetts | 01103 | — |
| Pfizer Investigational Site | West Yarmouth | Massachusetts | 02673 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48103 | — |
| Pfizer Investigational Site | Paw Paw | Michigan | 49079 | — |
| Pfizer Investigational Site | Royal Oak | Michigan | 48073 | — |
| Pfizer Investigational Site | Troy | Michigan | 48098 | — |
| Pfizer Investigational Site | Picayune | Mississippi | 39466 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63117 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68506 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68510 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68114 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89104 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89130 | — |
| Pfizer Investigational Site | New Brunswick | New Jersey | 08901 | — |
| Pfizer Investigational Site | Garden City | New York | 11530 | — |
| Pfizer Investigational Site | Kingston | New York | 12401 | — |
| Pfizer Investigational Site | Manlius | New York | 13104 | — |
| Pfizer Investigational Site | New York | New York | 10016 | — |
| Pfizer Investigational Site | Poughkeepsie | New York | 12601 | — |
| Pfizer Investigational Site | Rochester | New York | 14609 | — |
| Pfizer Investigational Site | Syracuse | New York | 13210 | — |
| Pfizer Investigational Site | Williamsville | New York | 14221 | — |
| Pfizer Investigational Site | Cary | North Carolina | 27518 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28204 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28207 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27609 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45212 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45249 | — |
| Pfizer Investigational Site | Bethany | Oklahoma | 73008 | — |
| Pfizer Investigational Site | Norman | Oklahoma | 73071 | — |
| Pfizer Investigational Site | Portland | Oregon | 97239 | — |
| Pfizer Investigational Site | Lansdale | Pennsylvania | 19446 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19115 | — |
| Pfizer Investigational Site | Sellersville | Pennsylvania | 18960 | — |
| Pfizer Investigational Site | State College | Pennsylvania | 16801 | — |
| Pfizer Investigational Site | Cranston | Rhode Island | 02920 | — |
| Pfizer Investigational Site | Cumberland | Rhode Island | 02864 | — |
| Pfizer Investigational Site | Warwick | Rhode Island | 02886 | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | 29464 | — |
| Pfizer Investigational Site | Bristol | Tennessee | 37620 | — |
| Pfizer Investigational Site | Johnson City | Tennessee | 36701 | — |
| Pfizer Investigational Site | Johnson City | Tennessee | 37601 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37203 | — |
| Pfizer Investigational Site | New Tazewell | Tennessee | 37825 | — |
| Pfizer Investigational Site | Bryan | Texas | 77802 | — |
| Pfizer Investigational Site | Corpus Christi | Texas | 78414 | — |
| Pfizer Investigational Site | Dallas | Texas | 75231 | — |
| Pfizer Investigational Site | Houston | Texas | 77079 | — |
| Pfizer Investigational Site | Longview | Texas | 75605 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | Arlington | Virginia | 22205 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23502 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23294 | — |
| Pfizer Investigational Site | Mountlake Terrace | Washington | 98043 | — |
| Pfizer Investigational Site | Spokane | Washington | 99207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00536484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2009 · Synced Apr 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00536484 live on ClinicalTrials.gov.